510(k) Report

510(k) · Cleared

Cleared

Endoxane

K971509510(k) TraditionalCleared Aug 21, 1997118-day reviewClass II21 CFR 878.3720

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Novatech SA · NWA Prosthesis, Tracheal, Preformed/Molded

Cleared on Aug 21, 1997 as substantially equivalent to K894380 (Bryan Corp., 1989) after a 118-day review. Its family tree reaches back 1 generation to 1989. 21 later devices descend from it.

Decided
Aug 21, 1997
Review
118 days
Class
Class II
Product code
NWA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K894380 (1989). 21 later devices descend from it, 6 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared2024: 2 descendants cleared2008: 1 descendant cleared2019: 1 descendant cleared2021: 2 descendants cleared2004: 1 descendant cleared2014: 3 descendants cleared2009: 1 descendant cleared2012: 1 descendant cleared2022: 2 descendants cleared2026: 2 descendants cleared2013: 1 descendant cleared2023: 1 descendant cleared2018: 1 descendant cleared2020: 1 descendant clearedK894380 · Dumon Tracheobronchial Stent · Bryan Corp. · 19891990200020102020
Descendants, by generation 1 generation forward: 6 descendants2 generations forward: 8 descendants3 generations forward: 5 descendants4 generations forward: 1 descendant5 generations forward: 1 descendant K894380 · Dumon Tracheobronchial Stent · Bryan Corp. · 19890+5
  1. Root · 1 generation backK894380 Dumon Tracheobronchial StentBryan Corp. · 1989
  2. This deviceK971509 EndoxaneNovatech SA · 1997
  3. Descendant · cites it directly · 15 of its ownK033053 Alveolus, TB-STS Tracheobronchial Stent SystemAlveolus, Inc. · 2004
  4. Descendant · cites it directly · 14 of its ownK062511 Aero Tracheobronchial Stent System, Model 90129-2XXAlveolus, Inc. · 2007
  5. Descendant · cites it directly · 11 of its ownK082284 Aero Tracheobronchial Stent Technology SystemAlveolus, Inc. · 2008
  6. Descendant · 2 generations on · 6 of its ownK083625 Aero DV Tracheobronchial Stent SystemAlveolus, Inc. · 2009
  7. Descendant · 2 generations on · 5 of its ownK121048 Ultraflex Tracheobronchial Stent System- Sterile UncoveredBoston Scientific Corp · 2012

Showing 5 of 21 descendants. See all descendants

Descendants cleared per year

2004: 12007: 12008: 12009: 12012: 12013: 12014: 32018: 12019: 12020: 12021: 22022: 22023: 12024: 22026: 2
2004high 3 (2014) · low 0 (2005)2026

Most influential descendants

Showing 5 of 21 · See all
  • K033053Alveolus, TB-STS Tracheobronchial Stent SystemAlveolus, Inc. · 2004 · cites it directly15descendants
  • K062511Aero Tracheobronchial Stent System, Model 90129-2XXAlveolus, Inc. · 2007 · cites it directly14descendants
  • K082284Aero Tracheobronchial Stent Technology SystemAlveolus, Inc. · 2008 · cites it directly11descendants
  • K083625Aero DV Tracheobronchial Stent SystemAlveolus, Inc. · 2009 · 2 generations on6descendants
  • K121048Ultraflex Tracheobronchial Stent System- Sterile UncoveredBoston Scientific Corp · 2012 · 2 generations on5descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K894380Dumon Tracheobronchial StentBryan Corp.1989—
0 (this device)K971509EndoxaneNovatech SA1997—
+1K033053Alveolus, TB-STS Tracheobronchial Stent SystemAlveolus, Inc.2004—
+1K062511Aero Tracheobronchial Stent System, Model 90129-2XXAlveolus, Inc.2007—
+1K082284Aero Tracheobronchial Stent Technology SystemAlveolus, Inc.2008—
+2K083625Aero DV Tracheobronchial Stent SystemAlveolus, Inc.2009—
+2K121048Ultraflex Tracheobronchial Stent System- Sterile UncoveredBoston Scientific Corp2012—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200710
200810
200910
201210
201310
201430
201810
201910
202010
202120
202220
202310
202420
202620
FIG. 1 — Lineage of K971509, 1989–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NWA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NWA device

  1. #1 K261541 VisionAir Enhanced Stock Stentscore 12.0 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K894380Dumon Tracheobronchial Stent
Summary page 5
…evice that we have cited for comparison is the ENDOXANE ® Stent, the same as ours, which was sold by our sole United States distributor, the Bryan Corporation (510K # K 4894380). The device description can be found in Section IV Description of Device. In short, the ENDOXANE® is an endoscopy stent made of…
Bryan Corp.1989—

What descends from it? (21)

See all 21

6 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K033053Alveolus, TB-STS Tracheobronchial Stent SystemAlveolus, Inc.200415
K062511Aero Tracheobronchial Stent System, Model 90129-2XXAlveolus, Inc.200714
K082284Aero Tracheobronchial Stent Technology SystemAlveolus, Inc.200811
K182743Patient-Specific Airway StentNew Cos, Inc.20192
K243126Tracheobronxane™ Dumon®Novatech SA20240
K212403Tracheal Stent System (Y-Shaped)Micro-Tech (Nanjing) Co., Ltd.20210

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K033053 (Alveolus, Inc., 2004) has gone furthest, with 15 descendants of its own.

How does its category compare?

All NWA devices

NWA Prosthesis, Tracheal, Preformed/Molded: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NWA

1in 2024

2019: 12022: 12024: 12026 (partial year): 1
2007high 1 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NWA

Too few NWA 510(k)s in any year since 2007 to give a median.

Recalls per year · NWA

No recall names NWA since 2007.

Adverse event reports per year · NWA

2in 2021

2019: 12021: 2
2007high 2 (2021) · low 0 (2007)2025

MAUDE reports naming product code NWA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20191—01
20200—00
20210—02
20221—00
20230—00
20241—00
20250—00
20261—0—

What is it indicated for?

The main indications according to their frequency are : 1. tracheobronchial tumors 2. Tracheal stenosis with scarring 3. Bronchial stenosis after surgical anastomotic, anastomoses resections or pulmonary transplantation. These stenoses have, as a common characteristic, the importance of the extrinsic compression or the collapse of the cartilingeous wall. The indication always focuses on an endoscopic therapeutic action, whether is concerns a resection or…

Read the full statement (112 words)

The main indications according to their frequency are :

1. tracheobronchial tumors

2. Tracheal stenosis with scarring

3. Bronchial stenosis after surgical anastomotic, anastomoses resections or pulmonary transplantation.

These stenoses have, as a common characteristic, the importance of the extrinsic compression or the collapse of the cartilingeous wall. The indication always focuses on an endoscopic therapeutic action, whether is concerns a resection or dilation. The stent insertion indication is indicated if the endoscopic resection is incomplete, in case of a persistent extrinsic compression, or if the lumen of the airway is insufficient. The most frequent locations are tracheal. The left main bronchus is the second location, followed by the right main bronchus.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K971509: Endoxane.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K971509

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026